These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29338083)

  • 1. Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?
    McHugh DJ; Root JC; Nelson CJ; Morris MJ
    Cancer; 2018 Apr; 124(7):1326-1334. PubMed ID: 29338083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
    Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
    Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
    Siebert AL; Lapping-Carr L; Morgans AK
    Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy for prostate cancer and risk of dementia.
    Robinson D; Garmo H; Van Hemelrijck M; Damber JE; Bratt O; Holmberg L; Wahlund LO; Stattin P; Adolfsson J
    BJU Int; 2019 Jul; 124(1):87-92. PubMed ID: 30637900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.
    Nead KT; Sinha S; Nguyen PL
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):259-264. PubMed ID: 28349979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
    Sun M; Cole AP; Hanna N; Mucci LA; Berry DL; Basaria S; Ahern DK; Kibel AS; Choueiri TK; Trinh QD
    J Urol; 2018 Jun; 199(6):1417-1425. PubMed ID: 29410294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer.
    Baik SH; Kury FSP; McDonald CJ
    J Clin Oncol; 2017 Oct; 35(30):3401-3409. PubMed ID: 28841388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
    Sari Motlagh R; Quhal F; Mori K; Miura N; Aydh A; Laukhtina E; Pradere B; Karakiewicz PI; Enikeev DV; Deuker M; Shariat SF
    J Urol; 2021 Jan; 205(1):60-67. PubMed ID: 32856962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database.
    Tae BS; Jeon BJ; Shin SH; Choi H; Bae JH; Park JY
    Cancer Res Treat; 2019 Apr; 51(2):593-602. PubMed ID: 30025445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea.
    Kang J; Shin DW; Han K; Park SH; Lee WG; Yoo JE; Woo SH; Park J
    Curr Probl Cancer; 2020 Dec; 44(6):100578. PubMed ID: 32360240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.
    Pierro MJ; Kilari D
    Eur Urol Focus; 2023 May; 9(3):409-410. PubMed ID: 37005166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training.
    Mundell NL; Daly RM; Macpherson H; Fraser SF
    Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition.
    Izard JP; Siemens DR
    Eur Urol Focus; 2020 Nov; 6(6):1162-1164. PubMed ID: 31911085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer.
    Khosrow-Khavar F; Rej S; Yin H; Aprikian A; Azoulay L
    J Clin Oncol; 2017 Jan; 35(2):201-207. PubMed ID: 27870566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies.
    Cui MF; Chen LM; Jiang C; Ma BZ; Yuan FW; Zhao C; Liu SM
    Support Care Cancer; 2024 Jul; 32(8):561. PubMed ID: 39085696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen deprivation therapy exacerbates Alzheimer's-associated cognitive decline via increased brain immune cell infiltration.
    Zhang C; Aida M; Saggu S; Yu H; Zhou L; Rehman H; Jiao K; Liu R; Wang L; Wang Q
    Sci Adv; 2024 Jun; 10(25):eadn8709. PubMed ID: 38905345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
    Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
    Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis.
    Hinojosa-Gonzalez DE; Zafar A; Saffati G; Kronstedt S; Zlatev DV; Khera M
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):507-519. PubMed ID: 38167924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
    Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.
    Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE
    Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.